A detailed history of Jones Financial Companies Lllp transactions in Novavax Inc stock. As of the latest transaction made, Jones Financial Companies Lllp holds 2,280 shares of NVAX stock, worth $21,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,280
Previous 837 172.4%
Holding current value
$21,705
Previous $10,000 180.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.71 - $17.11 $15,454 - $24,689
1,443 Added 172.4%
2,280 $28,000
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $3,255 - $17,551
837 New
837 $10,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $745M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.